Literature DB >> 10980746

Intravenous valproate is well tolerated in unstable patients with status epilepticus.

S Sinha1, D K Naritoku.   

Abstract

The authors reviewed hospital records of 13 patients with status epilepticus and hypotension who received IV valproate therapy. Most patients were elderly (74.4 +/- 12.5 [SD] years) and received a loading dose of valproate of 25.1 +/- 5.0 mg/kg (range 14.7 to 32.7), at a rate of 36.6 +/- 25.1 mg/min (range 6.3 to 100). There were no significant changes in blood pressure, pulse, or use of vasopressors. The data suggest that valproate loading is well tolerated, even in patients with cardiovascular instability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980746     DOI: 10.1212/wnl.55.5.722

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

Review 1.  New antiepileptic drugs.

Authors:  C W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

2.  Intravenous Valproate for Pediatric Status Epilepticus.

Authors:  Elizabeth Waterhouse
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

3.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

4.  The status of intravenous valproate for status.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2007 Jul-Aug       Impact factor: 7.500

5.  Intravenous valproate for status epilepticus ... An effective, yet still merely empirical alternative!

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2008 May-Jun       Impact factor: 7.500

Review 6.  Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.

Authors:  James H Fischer; Tejal V Patel; Patricia A Fischer
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Emergency Neurological Life Support: Status Epilepticus.

Authors:  Jan Claassen; Joshua N Goldstein
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

8.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 9.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 10.  Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?

Authors:  Thaddeus Walczak
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.